Home Biosimilar Antibodies Immunology & Inflammation Interleukins antibody Tralokinumab (Anti-IL-13) For research use only.
Not for use in humans.

Tralokinumab (Anti-IL-13)

Synonyms:

Tralokinumab (Anti-IL-13) is a fully human IgG4 monoclonal antibody specifically targeting IL-13 with high affinity. It can be used for the research of the atopic dermatitis (AD). MW :145.5 KD.

Tralokinumab (Anti-IL-13)

Purity & Quality Control

≥99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Tralokinumab (Anti-IL-13) is a fully human IgG4 monoclonal antibody specifically targeting IL-13 with high affinity. It can be used for the research of the atopic dermatitis (AD). MW :145.5 KD.

Product Details

CAS No. 1044515-88-9
Molecular Weight 145.5 kDa
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Tralokinumab (Anti-IL-13) | Tralokinumab (Anti-IL-13) supplier | purchase Tralokinumab (Anti-IL-13) | Tralokinumab (Anti-IL-13) cost | Tralokinumab (Anti-IL-13) manufacturer | order Tralokinumab (Anti-IL-13) | Tralokinumab (Anti-IL-13) distributor